Hudson Bay Capital Management LP Nuvation Bio Inc. Transaction History

Hudson Bay Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$4.6 - $8.83 $2.3 Million - $4.42 Million	-500,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.78 - $10.0 $5,477 - $7,040	-704 Reduced 0.14%	500,000 $4.97 Million
Q2 2021 Aug 16, 2021	SELL	$9.22 - $14.48 $6.27 Million - $9.84 Million	-679,630 Reduced 57.58%	500,704 $4.66 Million
Q1 2021 May 14, 2021	BUY	$9.0 - $14.57 $10.6 Million - $17.2 Million	1,180,334 New	1,180,334 $12.3 Million

152

123M

9.7K

6.5K

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $480M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.